Compagnie Lombard Odier SCmA’s NovoCure NVCR Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.1K	Sell	930 -3,000	-76%	-$37.5K	﹤0.01%	388
2025 Q4	$50.8K	Hold	3,930	–	–	﹤0.01%	335
2025 Q3	$50.8K	Hold	3,930	–	–	﹤0.01%	342
2025 Q2	$70K	Hold	3,930	–	–	﹤0.01%	309
2025 Q1	$70K	Hold	3,930	–	–	﹤0.01%	334
2024 Q4	$117K	Hold	3,930	–	–	﹤0.01%	283
2024 Q3	$61.4K	Hold	3,930	–	–	﹤0.01%	327
2024 Q2	$67.3K	Hold	3,930	–	–	﹤0.01%	314
2024 Q1	$61.4K	Hold	3,930	–	–	﹤0.01%	341
2023 Q4	$58.7K	Hold	3,930	–	–	﹤0.01%	394
2023 Q3	$63.5K	Hold	3,930	–	–	﹤0.01%	400
2023 Q2	$163K	Hold	3,930	–	–	﹤0.01%	300
2023 Q1	$236K	Buy	3,930 +850	+28%	+$67.9K	0.01%	264
2022 Q4	$226K	Hold	3,080	–	–	0.01%	276
2022 Q3	$234K	Hold	3,080	–	–	0.01%	280
2022 Q2	$214K	Hold	3,080	–	–	0.01%	285
2022 Q1	$255K	Hold	3,080	–	–	0.01%	281
2021 Q4	$231K	Buy	3,080 +40	+1%	+$4.01K	﹤0.01%	338
2021 Q3	$354K	Hold	3,040	–	–	0.01%	287
2021 Q2	$674K	Hold	3,040	–	–	0.01%	198
2021 Q1	$402K	Buy	3,040 +40	+1%	+$6.33K	0.01%	309
2020 Q4	$519K	Hold	3,000	–	–	0.01%	219
2020 Q3	$334K	Hold	3,000	–	–	0.01%	227
2020 Q2	$178K	Hold	3,000	–	–	0.01%	276
2020 Q1	$202K	Hold	3,000	–	–	0.01%	241
2019 Q4	$253K	Hold	3,000	–	–	0.01%	235
2019 Q3	$224K	Buy	+3,000	New	+$240K	0.01%	237

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Compagnie Lombard Odier SCmA's NVCR Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA reduced its NovoCure (NVCR) stake by 76% in Q1 2026, selling an estimated $37.5K and leaving 930 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #388.

Compagnie Lombard Odier SCmA first reported a position in NVCR in Q3 2019 and has held it in 27 quarters since. The position peaked at $674K in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Compagnie Lombard Odier SCmA held 930 shares of NovoCure worth $10.1K as of Q1 2026.
Compagnie Lombard Odier SCmA sold 3,000 NovoCure shares in Q1 2026, an estimated $37.5K.
NovoCure made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #388 holding.
Compagnie Lombard Odier SCmA first reported a position in NovoCure in Q3 2019 and has held it in 27 quarters since.
Compagnie Lombard Odier SCmA's NovoCure position peaked at $674K in Q2 2021.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.